E. Clauser

Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling
202216 citationsauthor #8
Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction
202029 citationsauthor #14
Mutations affecting the conserved acidic WNK1 motif cause inherited hyperkalemic hyperchloremic acidosis.
202028 citationsauthor #27
Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation.
202018 citationsauthor #8
TREM-1 orchestrates Angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm.
202068 citationsauthor #17
Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
201924 citationsauthor #5
Carney complex revealed by a cerebellar ischaemic stroke in a 6‐year‐old girl
20181 citationsauthor #6
Angiotensin I-converting enzyme (ACE) gene structure and polymorphism: Relation to enzyme function and gene expression
20181 citationsauthor #4
Cullin 3 is a partner of armadillo repeat containing 5 (ARMC5), the product of the gene responsible for primary bilateral macronodular adrenal hyperplasia
20181 citationsauthor #2
Knock‐In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP‐Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis
201711 citationsauthor #7
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.
201740 citationsauthor #17
Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
201715 citationsauthor #8
[OP.LB01.10] THE SKIPPING OF EXON 9 IN CULLIN-3 CAUSES A SEVERE FORM OF FAMILIAL HYPERKALEMIC HYPERTENSION IN MICE
20160 citationsauthor #4
Knock in of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-dependent Protein Kinase A Activation: A Model of Acrodysostosis Type 1?
20160 citationsauthor #5
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.
201665 citationsauthor #42
Focal DNA methylation measurement in adrenocortical carcinoma is a prognostic marker independent from tumor stage and Ki67; an ENSAT study
20160 citationsauthor #18
Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
201633 citationsauthor #9
Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex*
201531 citationsauthor #9
Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
201533 citationsauthor #13
IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma
201446 citationsauthor #18
Immunohistochemistry versus next-generation sequencing for the routine detection of BRAF V600E mutation in melanomas.
20148 citationsauthor #4
Integrated genomic characterization of adrenocortical carcinoma
2014610 citationsauthor #28
Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion.
20148 citationsauthor #17
Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
201436 citationsauthor #9
A feminizing adrenocortical carcinoma in the context of a late onset 21-hydroxylase deficiency.
201412 citationsauthor #7
CO-13 - Spectrum of KLHL3 and Cullin-3 mutations in familial hyperkalemic hypertension
20130 citationsauthor #5
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
201390 citationsauthor #13
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
2013115 citationsauthor #15
Analysis of BRAF mutations in circulating tumor cells selected by size from patients with melanoma and comparision to the primary tumor.
20122 citationsauthor #7
PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.
2012110 citationsauthor #24
Steroid 21-hydroxylase gene mutational spectrum in 50 Tunisian patients: characterization of three novel polymorphisms.
201214 citationsauthor #3
A revolution in the diagnosis of adrenal disorders: rapid multiplex quantitation of serum steroids by means of tandem mass spectrometry (MSMS)
20121 citationsauthor #8
Acrodysostosis syndromes.
201233 citationsauthor #6
Clinical and pathophysiological implications of chromosomal alterations in adrenocortical tumors: an integrated genomic approach.
201253 citationsauthor #11
Clinical Features and Treatment of Pediatric Somatotropinoma: Case Study of an Aggressive Tumor due to a New AIP Mutation and Extensive Literature Review
201132 citationsauthor #8
[Assessment of AFP in amniotic fluid: comparison of three automated techniques].
20113 citationsauthor #5
Subject Index Vol. 75, 2011
20110 citationsauthor #48
Contents Vol. 75, 2011
20110 citationsauthor #48
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.
2011153 citationsauthor #11
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
201198 citationsauthor #10
The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses.
201046 citationsauthor #6
Genomic DNA alterations in adrenocortical tumors (ACTs): diagnostic and prognostic value
20100 citationsauthor #8
CAN-10-2014 Cancer esearch rity Report nscriptome Analysis Reveals that p 53 and β-Catenin rations Occur in a Group of Aggressive R enocortical Cancers
20100 citationsauthor #7
Mutations and polymorphisms in the gene encoding regulatory subunit type 1‐alpha of protein kinase A (PRKAR1A): an update
2010174 citationsauthor #11
Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.
2010101 citationsauthor #9
Frequent phosphodiesterase 11a (pde11a4) gene mutations in patients with carney complex (cnc) due to prkar1a mutations and adrenal (ppnad) and Sertoli cell tumors (lccsct): a digenic disorder?
20101 citationsauthor #8
Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.
2010144 citationsauthor #7
CARDIOVASCULAR RHYTHMS AND CARDIAC BAROREFLEX SENSITIVITY IN AT1A RECEPTOR GAIN-OF-FUNCTION MUTANT MICE
201014 citationsauthor #5
ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.
201028 citationsauthor #9
Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
201060 citationsauthor #10
Systematic Analysis of G Protein-Coupled Receptor Gene Expression in Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia Identifies Novel Targets for Pharmacological Control of Adrenal Cushing’s Syndrome
20100 citationsauthor #10
hypertension Angiotensin II type 1 receptor gene polymorphisms in human essential
2009100 citationsauthor #6
Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.
2009358 citationsauthor #9
P-33: Substitution of the glycophorin A transmembrane domain modifies the structure of the insulin receptor and inhibits the action of insulin
20090 citationsauthor #3
[Structure and functions of the angiotensin II AT1 receptors during evolution].
20090 citationsauthor #2
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
2009394 citationsauthor #15
Angiotensin II AT1 receptor constitutive activation: from molecular mechanisms to pathophysiology.
200912 citationsauthor #2
Role of angiotensin II AT1 receptor activation in cardiovascular diseases.
2008103 citationsauthor #4
Communications orales - Hypophyse
20080 citationsauthor #12
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
2007131 citationsauthor #9
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.
200781 citationsauthor #15
Pharmacological chaperones rescue the membrane expression and function of a mutant of the vasopressin V1b/V3 receptor
20070 citationsauthor #1
Genotype/phenotype correlation of PRKAR1A mutations in patients with Carney complex (CNC) and/or sporadic primary pigmented nodular adrenocortical disease (PPNAD) from the CNC network
20060 citationsauthor #5
The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II.
200614 citationsauthor #4
Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis.
200530 citationsauthor #10
[Familial aspect of primary hyperaldosteronism: analysis of families compatible with primary hyperaldosteronism type 2].
200510 citationsauthor #4
A Novel C-terminal Motif Is Necessary for the Export of the Vasopressin V1b/V3 Receptor to the Plasma Membrane*
200585 citationsauthor #2
Methods Patient Population Hypertensive Index Cases and Sibships With Multiple Hypertensive Subjects
20050 citationsauthor #6
Mechanisms of Cell-surface Rerouting of an Endoplasmic Reticulum-retained Mutant of the Vasopressin V1b/V3 Receptor by a Pharmacological Chaperone*
200571 citationsauthor #4
Inhibition by transmembrane peptides of chimeric insulin receptors
200541 citationsauthor #4
Immunocytochemical localization of angiotensinogen in rat liver and kidney
200457 citationsauthor #4
A Novel Carboxyl-Terminal Motif is Necessary for the Export of the Vasopressin V 1 b / V 3 Receptor to the Plasma Membrane
20040 citationsauthor #2
AT1 Receptor Molecular Aspects
20041 citationsauthor #2
[Genetics in endocrinology].
20030 citationsauthor #1
Lessons from constitutively active mutants of G protein-coupled receptors.
2002200 citationsauthor #5
Constitutive Internalization of Constitutively Active Angiotensin II AT1A Receptor Mutants Is Blocked by Inverse Agonists*
200267 citationsauthor #5
A functional enhanced green fluorescent protein (EGFP)-tagged angiotensin II at(1a) receptor recruits the endogenous Galphaq/11 protein to the membrane and induces its specific internalization independently of receptor-g protein coupling in HEK-293 cells.
200130 citationsauthor #5
The Expression of Thyrotropin Receptor in the Brain *
200137 citationsauthor #6
[Synthesis and local and distant actions of vasoactive peptides].
20002 citationsauthor #1
Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay.
200075 citationsauthor #6
Sheep 5HT2A receptors: partial cloning of the coding sequence and mRNA localization by in situ hybridization in the ewe hypothalamus
19997 citationsauthor #4
Several interesting phenotypes of the AT1 receptor produced by site-directed mutagenesis.
19999 citationsauthor #6
Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action
199919 citationsauthor #3
Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor.
199943 citationsauthor #5
Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants.
19987 citationsauthor #2
[Molecular structure and function of angiotensin ii receptors].
19989 citationsauthor #1
Identification of the Rat Adapter Grb14 as an Inhibitor of Insulin Actions*
1998106 citationsauthor #4
A noninternalized nondesensitized truncated AT1A receptor transduces an amplified ANG II signal.
19984 citationsauthor #4
A noninternalized nondesensitized truncated AT1A receptor transduces an amplified ANG II signal.
199831 citationsauthor #4
[Angiotensin II receptors: classification, structure, and signal transduction].
19984 citationsauthor #2
Récepteurs de l'angiotensine II: classification, structure et transduction du signal.
19980 citationsauthor #2
Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.
199880 citationsauthor #9
Detection and quantification of the A3243G mutation of mitochondrial DNA by ligation detection reaction.
19988 citationsauthor #3
[Physiology and functional investigation of adrenal glands].
19984 citationsauthor #1
Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.
199816 citationsauthor #4
The C-terminal Third Intracellular Loop of the Rat AT1A Angiotensin Receptor Plays a Key Role in G Protein Coupling Specificity and Transduction of the Mitogenic Signal*
199763 citationsauthor #5
Contents, Vol. 47, 1997
19970 citationsauthor #107
Subject Index Vol. 47, 1997
19970 citationsauthor #107
Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma.
199750 citationsauthor #5
Cleavage site mutants of the subtype B insulin receptor are uncleaved and fully functional.
19973 citationsauthor #4

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT